PGNX - Progenics Pharmaceuticals EPS beats by $0.03 misses on revenue May, 07 2020 07:32 AM Progenics Pharmaceuticals Inc. Progenics Pharmaceuticals (NASDAQ:PGNX): Q1 GAAP EPS of -$0.19 beats by $0.03.More news on: Progenics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...